The U.S. Food and Drug Administration (FDA) launched Elsa, a generative AI tool aimed at enhancing operational efficiency for its employees. Elsa assists with reading, writing, summarizing, and reviewing scientific protocols, accelerating evaluations and identifying priority tasks securely within a GovCloud environment. Its initial rollout is ahead of schedule and under budget, representing a significant step in the FDA’s adoption of AI technologies to modernize agency functions. Elsa’s capabilities are expected to expand as employee needs evolve, with the overarching aim of improving FDA processes while safeguarding sensitive data.
Related articles:
HHS Expands Use of AI Across U.S. Healthcare Programs
Advancing Trustworthy AI in Health and Human Services
AI and Automation in the Federal Government
The Future of AI Regulation in Health Care
